An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

An inexpensive, long-approved HIV drug can improve vision in patients with a blinding complication of diabetes more ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ranibizumab, is delivered through an ocular implant that is refilled every nine ...

One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Diabetic retinopathy affects almost 10 million people in the US and is the third FDA-approved indication for Susvimo, which is also approved for treating neovascular or ‘wet’ age-related macular ...

BoNT-A injections may temporarily impair ocular surface stability, affecting meibomian gland function and tear film stability.

On 27 December 2023, EEA were issued 500 million options exercisable at $0.07 each and expiring 26 December 2026, following the completion of a strategic investment of $24.7 million by EEA in December ...

Injection of an antibiotic and glucocorticoid after cataract surgery is far cheaper and as safe as a protocol 12 drops daily ...

Hot on the heels of a $150 million fundraise, Atsena Therapeutics is back with early-stage data for the company’s eye disease ...